4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide

C44H46N8O6 — CID 167508343

IUPAC4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide
SMILESC[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc(-c4cnn(CCCC5CCN(c6cccc7c6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)c4)cc3)ccc2o1
InChIInChI=1S/C44H46N8O6/c1-27-5-3-19-50(27)26-39-47-34-23-32(13-15-37(34)58-39)46-41(54)30-11-9-29(10-12-30)31-24-45-51(25-31)20-4-6-28-17-21-49(22-18-28)35-8-2-7-33-40(35)44(57)52(43(33)56)36-14-16-38(53)48-42(36)55/h2,7-13,15,23-25,27-28,36H,3-6,14,16-22,26H2,1H3,(H,46,54)(H,48,53,55)/t27-,36?/m0/s1
InChIKeyUNXZBRKZFRHWHU-XLYAUNJQSA-N
MW782.90 g/mol
LogP6.03
Rot. Bonds11

About 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide

4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide (PubChem CID 167508343) has the molecular formula C44H46N8O6 and a molecular weight of 782.90 g/mol. Its IUPAC name is 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide.

Molecular Properties

Compound Name4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide
PubChem CID167508343
Molecular FormulaC44H46N8O6
Molecular Weight782.90 g/mol
Exact Mass782.35
IUPAC Name4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide
SMILESC[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc(-c4cnn(CCCC5CCN(c6cccc7c6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)c4)cc3)ccc2o1
InChIInChI=1S/C44H46N8O6/c1-27-5-3-19-50(27)26-39-47-34-23-32(13-15-37(34)58-39)46-41(54)30-11-9-29(10-12-30)31-24-45-51(25-31)20-4-6-28-17-21-49(22-18-28)35-8-2-7-33-40(35)44(57)52(43(33)56)36-14-16-38(53)48-42(36)55/h2,7-13,15,23-25,27-28,36H,3-6,14,16-22,26H2,1H3,(H,46,54)(H,48,53,55)/t27-,36?/m0/s1
InChIKeyUNXZBRKZFRHWHU-XLYAUNJQSA-N
XLogP6.03
TPSA162.98 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds11
Heavy Atoms58
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500782.90
LogP ≤ 56.03
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide?
The IUPAC name of 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide (CID 167508343) is 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide.
What is the SMILES notation for 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide?
The canonical SMILES for 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide is C[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc(-c4cnn(CCCC5CCN(c6cccc7c6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)c4)cc3)ccc2o1.
What is the InChIKey of 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide?
The InChIKey is UNXZBRKZFRHWHU-XLYAUNJQSA-N. The full InChI is InChI=1S/C44H46N8O6/c1-27-5-3-19-50(27)26-39-47-34-23-32(13-15-37(34)58-39)46-41(54)30-11-9-29(10-12-30)31-24-45-51(25-31)20-4-6-28-17-21-49(22-18-28)35-8-2-7-33-40(35)44(57)52(43(33)56)36-14-16-38(53)48-42(36)55/h2,7-13,15,23-25,27-28,36H,3-6,14,16-22,26H2,1H3,(H,46,54)(H,48,53,55)/t27-,36?/m0/s1.
What are the key properties of 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide?
4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide has a molecular weight of 782.90 g/mol, XLogP of 6.03, 11 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[1-[3-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperidin-4-yl]propyl]pyrazol-4-yl]-N-[2-[[(2S)-2-methylpyrrolidin-1-yl]methyl]-1,3-benzoxazol-5-yl]benzamide is sourced from PubChem (CID 167508343), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).